drugset / Trial / NCT04163263
Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of Repeat Topical Application of BOS-356 in Subjects With Moderate to Severe Acne Vulgaris
RandomizedSequentialTriple-blindTreatment
Summary
This study is being conducted to characterize the safety and tolerability of BOS-356 in adult participants with moderate to severe acne vulgaris following 14 days or 28 days of repeated topical application
Timeline
- Start
- 2019-11-04
- Primary completion
- 2020-11-11
- Completion
- 2020-11-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BOS-356 | Unknown | 0.1 % | Topical |
| Subject | BOS-356 | Unknown | 0.4 % | Topical |
| Subject | BOS-356 | Unknown | 0.7 % | Topical |